Medication Assessment Through Real Time Information eXchange - Distributed Pharmaceutical Record System (MATRIX-DPRS)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03076853|
Recruitment Status : Completed
First Posted : March 10, 2017
Last Update Posted : March 10, 2017
|Condition or disease||Intervention/treatment|
|Patients With Pharmaceutical Record||Other: Opening of the Pharmaceutical Record|
|Study Type :||Observational|
|Actual Enrollment :||511 participants|
|Official Title:||Medication Assessment Through Real Time Information eXchange - Distributed Pharmaceutical Record System|
|Actual Study Start Date :||April 3, 2016|
|Actual Primary Completion Date :||June 30, 2016|
|Actual Study Completion Date :||June 30, 2016|
|Patients with Pharmaceutical Record||
Other: Opening of the Pharmaceutical Record
After a first prescription without the pharmaceutical record, the study investigator has to open the pharmaceutical record to obtain some additional data. After, he has to choose between maintain or modify his first prescription.
- Modification of the medical prescription linked to the use of the pharmaceutical record [ Time Frame: 3 months ]The primary outcome measure is to evaluate the impact of the use of the pharmaceutical record on th medical prescription. The doctor writes a first medical prescription without using the pharmaceutical record and a second with the pharmaceutical record.The changes are analyzed.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03076853
|CHU de Nice|
|Nice, France, 06000|